Spanish expert consensus on the use of safinamide in Parkinson's disease.
Sign Up to like & getrecommendations! Published in 2018 at "Neurologia"
DOI: 10.1016/j.nrl.2018.04.007
Abstract: Safinamide is a new add-on drug to levodopa for the treatment of Parkinson's disease (PD) with motor fluctuations. Due to the recent incorporation of safinamide into routine clinical practice, no post-authorisation phase IV studies on… read more here.
Keywords: consensus use; expert consensus; parkinson; spanish expert ... See more keywords